Fangfang Chen

10PUBLICATIONS
18CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Micro- and nanosystemsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Solid tumoursNanomedicine
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|May 05, 2026
Protein Corona-Tailored Nanoplatform Boosts Tumor Accumulation and Reprograms Macrophages for Osteosarcoma Therapy.

|Apr 10, 2026
A Hydrogen-Releasing Nanozyme Engineers a Mitochondrial ROS Amplifier for Self-Sustaining Catalytic Immunotherapy.

Mingfan Shi, Jingrui Cao, Tong Wu

|Feb 18, 2026
Targeting inflammatory microenvironments: overcoming therapy resistance and immunosuppression.

Yumei Zhou, Minghua Bai, Longjiao Chen

|Oct 30, 2025
Nanotechnology-Driven Strategies in Osteosarcoma Advances in Treatment: Immunotherapy and Drug Delivery.

Wenwen Su, Yuanyuan Li, Guang Yang

|Dec 18, 2024
Dual-Targeted Drug Delivery to Myeloid Leukemia Cells via Complement- and Transferrin-Based Protein Corona.

Wen Wu, Yuanyuan Li, Qihui Liu

|Nov 29, 2024
Specific surface-modified iron oxide nanoparticles trigger complement-dependent innate and adaptive antileukaemia immunity.

Yuanyuan Li, Wen Wu, Qihui Liu

Pageof 2

Frequent Collaborators

4 joint publications

Qihui Liu

2 joint publications

Yuanyuan Li

1 joint publications

Xiaoqing Hu

1 joint publications

Jiabin Wang